nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.214	1	CbGaD
Propafenone—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.184	0.562	CrCrCtD
Propafenone—Labetalol—Formoterol—chronic obstructive pulmonary disease	0.0718	0.219	CrCrCtD
Propafenone—Labetalol—Arformoterol—chronic obstructive pulmonary disease	0.0718	0.219	CrCrCtD
Propafenone—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0686	0.207	CbGbCtD
Propafenone—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.052	0.157	CbGbCtD
Propafenone—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.052	0.157	CbGbCtD
Propafenone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0157	0.0474	CbGbCtD
Propafenone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0145	0.0436	CbGbCtD
Propafenone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0145	0.0436	CbGbCtD
Propafenone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0137	0.0412	CbGbCtD
Propafenone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0132	0.0399	CbGbCtD
Propafenone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0132	0.0399	CbGbCtD
Propafenone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0118	0.0356	CbGbCtD
Propafenone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0111	0.0335	CbGbCtD
Propafenone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.011	0.0331	CbGbCtD
Propafenone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0075	0.0226	CbGbCtD
Propafenone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00716	0.0216	CbGbCtD
Propafenone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00638	0.0192	CbGbCtD
Propafenone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00625	0.0188	CbGbCtD
Propafenone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0059	0.0178	CbGbCtD
Propafenone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00374	0.0113	CbGbCtD
Propafenone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00354	0.0107	CbGbCtD
Propafenone—Salmeterol—ADRB2—chronic obstructive pulmonary disease	0.00028	0.0947	CrCbGaD
Propafenone—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000273	0.0923	CrCbGaD
Propafenone—Quinapril—ACE—chronic obstructive pulmonary disease	0.000271	0.0915	CrCbGaD
Propafenone—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.00027	0.0912	CrCbGaD
Propafenone—Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.00025	0.0844	CrCbGaD
Propafenone—Benazepril—ACE—chronic obstructive pulmonary disease	0.000235	0.0796	CrCbGaD
Propafenone—Carvedilol—VEGFA—chronic obstructive pulmonary disease	0.000219	0.074	CrCbGaD
Propafenone—Labetalol—ADRB2—chronic obstructive pulmonary disease	0.000179	0.0605	CrCbGaD
Propafenone—Mirabegron—ALB—chronic obstructive pulmonary disease	0.000146	0.0495	CrCbGaD
Propafenone—Carvedilol—ADRB2—chronic obstructive pulmonary disease	0.000123	0.0417	CrCbGaD
Propafenone—Carvedilol—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.0357	CrCbGaD
Propafenone—Carvedilol—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.0344	CrCbGaD
Propafenone—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	9.5e-05	0.0321	CrCbGaD
Propafenone—Propranolol—ADRB2—chronic obstructive pulmonary disease	9.37e-05	0.0317	CrCbGaD
Propafenone—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	8.96e-05	0.0303	CrCbGaD
Propafenone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	8.67e-05	0.000866	CcSEcCtD
Propafenone—Oedema—Montelukast—chronic obstructive pulmonary disease	8.67e-05	0.000866	CcSEcCtD
Propafenone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	8.64e-05	0.000863	CcSEcCtD
Propafenone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	8.64e-05	0.000863	CcSEcCtD
Propafenone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	8.62e-05	0.000861	CcSEcCtD
Propafenone—Infection—Montelukast—chronic obstructive pulmonary disease	8.62e-05	0.000861	CcSEcCtD
Propafenone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	8.61e-05	0.000859	CcSEcCtD
Propafenone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	8.6e-05	0.000859	CcSEcCtD
Propafenone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	8.6e-05	0.000859	CcSEcCtD
Propafenone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	8.57e-05	0.000856	CcSEcCtD
Propafenone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.000852	CcSEcCtD
Propafenone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	8.51e-05	0.000849	CcSEcCtD
Propafenone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	8.49e-05	0.000848	CcSEcCtD
Propafenone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000848	CcSEcCtD
Propafenone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	8.43e-05	0.000841	CcSEcCtD
Propafenone—Oedema—Salbutamol—chronic obstructive pulmonary disease	8.36e-05	0.000835	CcSEcCtD
Propafenone—Infection—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.00083	CcSEcCtD
Propafenone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	8.27e-05	0.000826	CcSEcCtD
Propafenone—Hypotension—Formoterol—chronic obstructive pulmonary disease	8.27e-05	0.000826	CcSEcCtD
Propafenone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	8.27e-05	0.000826	CcSEcCtD
Propafenone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	8.23e-05	0.000822	CcSEcCtD
Propafenone—Shock—Salbutamol—chronic obstructive pulmonary disease	8.23e-05	0.000821	CcSEcCtD
Propafenone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	8.22e-05	0.00082	CcSEcCtD
Propafenone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	8.2e-05	0.000819	CcSEcCtD
Propafenone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	8.16e-05	0.000815	CcSEcCtD
Propafenone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000814	CcSEcCtD
Propafenone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	8.12e-05	0.000811	CcSEcCtD
Propafenone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	8.08e-05	0.000807	CcSEcCtD
Propafenone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	8.08e-05	0.000807	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	8.07e-05	0.000806	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	8.07e-05	0.000806	CcSEcCtD
Propafenone—Propranolol—CYP1A1—chronic obstructive pulmonary disease	8.04e-05	0.0272	CrCbGaD
Propafenone—Insomnia—Formoterol—chronic obstructive pulmonary disease	8.01e-05	0.0008	CcSEcCtD
Propafenone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	8.01e-05	0.0008	CcSEcCtD
Propafenone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	7.97e-05	0.000796	CcSEcCtD
Propafenone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	7.96e-05	0.000795	CcSEcCtD
Propafenone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000792	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	7.9e-05	0.000789	CcSEcCtD
Propafenone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	7.89e-05	0.000788	CcSEcCtD
Propafenone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	7.89e-05	0.000788	CcSEcCtD
Propafenone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	7.87e-05	0.000786	CcSEcCtD
Propafenone—Somnolence—Formoterol—chronic obstructive pulmonary disease	7.87e-05	0.000786	CcSEcCtD
Propafenone—Insomnia—Montelukast—chronic obstructive pulmonary disease	7.85e-05	0.000783	CcSEcCtD
Propafenone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000781	CcSEcCtD
Propafenone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	7.81e-05	0.00078	CcSEcCtD
Propafenone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	7.8e-05	0.000778	CcSEcCtD
Propafenone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	7.8e-05	0.000778	CcSEcCtD
Propafenone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	7.79e-05	0.000778	CcSEcCtD
Propafenone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	7.76e-05	0.000775	CcSEcCtD
Propafenone—Propranolol—CYP1A2—chronic obstructive pulmonary disease	7.75e-05	0.0262	CrCbGaD
Propafenone—Somnolence—Montelukast—chronic obstructive pulmonary disease	7.71e-05	0.00077	CcSEcCtD
Propafenone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	7.69e-05	0.000768	CcSEcCtD
Propafenone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	7.68e-05	0.000766	CcSEcCtD
Propafenone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	7.65e-05	0.000763	CcSEcCtD
Propafenone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	7.65e-05	0.000763	CcSEcCtD
Propafenone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	7.64e-05	0.000762	CcSEcCtD
Propafenone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	7.63e-05	0.000762	CcSEcCtD
Propafenone—Fatigue—Formoterol—chronic obstructive pulmonary disease	7.63e-05	0.000762	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	7.62e-05	0.000761	CcSEcCtD
Propafenone—Pain—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.000756	CcSEcCtD
Propafenone—Pain—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.000756	CcSEcCtD
Propafenone—Constipation—Arformoterol—chronic obstructive pulmonary disease	7.57e-05	0.000756	CcSEcCtD
Propafenone—Constipation—Formoterol—chronic obstructive pulmonary disease	7.57e-05	0.000756	CcSEcCtD
Propafenone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	7.56e-05	0.000755	CcSEcCtD
Propafenone—Amnesia—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000754	CcSEcCtD
Propafenone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	7.51e-05	0.00075	CcSEcCtD
Propafenone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	7.49e-05	0.000748	CcSEcCtD
Propafenone—Fatigue—Montelukast—chronic obstructive pulmonary disease	7.48e-05	0.000747	CcSEcCtD
Propafenone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	7.45e-05	0.000744	CcSEcCtD
Propafenone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	7.43e-05	0.000742	CcSEcCtD
Propafenone—Pain—Montelukast—chronic obstructive pulmonary disease	7.42e-05	0.000741	CcSEcCtD
Propafenone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	7.4e-05	0.000739	CcSEcCtD
Propafenone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	7.37e-05	0.000736	CcSEcCtD
Propafenone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	7.36e-05	0.000735	CcSEcCtD
Propafenone—Purpura—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000735	CcSEcCtD
Propafenone—Rash—Aminophylline—chronic obstructive pulmonary disease	7.34e-05	0.000733	CcSEcCtD
Propafenone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	7.33e-05	0.000732	CcSEcCtD
Propafenone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	7.3e-05	0.000729	CcSEcCtD
Propafenone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	7.3e-05	0.000729	CcSEcCtD
Propafenone—Headache—Aminophylline—chronic obstructive pulmonary disease	7.29e-05	0.000728	CcSEcCtD
Propafenone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	7.27e-05	0.000726	CcSEcCtD
Propafenone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000726	CcSEcCtD
Propafenone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	7.26e-05	0.000725	CcSEcCtD
Propafenone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	7.24e-05	0.000723	CcSEcCtD
Propafenone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	7.24e-05	0.000723	CcSEcCtD
Propafenone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	7.22e-05	0.000721	CcSEcCtD
Propafenone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	7.21e-05	0.00072	CcSEcCtD
Propafenone—Constipation—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.000714	CcSEcCtD
Propafenone—Pain—Salbutamol—chronic obstructive pulmonary disease	7.15e-05	0.000714	CcSEcCtD
Propafenone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	7.09e-05	0.000708	CcSEcCtD
Propafenone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000708	CcSEcCtD
Propafenone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	7.03e-05	0.000703	CcSEcCtD
Propafenone—Urticaria—Formoterol—chronic obstructive pulmonary disease	7.03e-05	0.000703	CcSEcCtD
Propafenone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	7e-05	0.000699	CcSEcCtD
Propafenone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	7e-05	0.000699	CcSEcCtD
Propafenone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	7e-05	0.000699	CcSEcCtD
Propafenone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	7e-05	0.000699	CcSEcCtD
Propafenone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	6.98e-05	0.000697	CcSEcCtD
Propafenone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000692	CcSEcCtD
Propafenone—Rash—Tiotropium—chronic obstructive pulmonary disease	6.92e-05	0.000691	CcSEcCtD
Propafenone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	6.91e-05	0.00069	CcSEcCtD
Propafenone—Nausea—Aminophylline—chronic obstructive pulmonary disease	6.91e-05	0.00069	CcSEcCtD
Propafenone—Urticaria—Montelukast—chronic obstructive pulmonary disease	6.89e-05	0.000688	CcSEcCtD
Propafenone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	6.89e-05	0.000688	CcSEcCtD
Propafenone—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	6.88e-05	0.0233	CrCbGaD
Propafenone—Headache—Tiotropium—chronic obstructive pulmonary disease	6.87e-05	0.000686	CcSEcCtD
Propafenone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	6.87e-05	0.000686	CcSEcCtD
Propafenone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	6.86e-05	0.000685	CcSEcCtD
Propafenone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	6.86e-05	0.000685	CcSEcCtD
Propafenone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	6.84e-05	0.000683	CcSEcCtD
Propafenone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	6.78e-05	0.000678	CcSEcCtD
Propafenone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.000674	CcSEcCtD
Propafenone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000673	CcSEcCtD
Propafenone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	6.64e-05	0.000663	CcSEcCtD
Propafenone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	6.61e-05	0.00066	CcSEcCtD
Propafenone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	6.61e-05	0.00066	CcSEcCtD
Propafenone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	6.52e-05	0.000652	CcSEcCtD
Propafenone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	6.52e-05	0.000652	CcSEcCtD
Propafenone—Nausea—Tiotropium—chronic obstructive pulmonary disease	6.52e-05	0.000651	CcSEcCtD
Propafenone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	6.51e-05	0.00065	CcSEcCtD
Propafenone—Dry skin—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000649	CcSEcCtD
Propafenone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000644	CcSEcCtD
Propafenone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	6.39e-05	0.000638	CcSEcCtD
Propafenone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	6.35e-05	0.000634	CcSEcCtD
Propafenone—Asthenia—Formoterol—chronic obstructive pulmonary disease	6.35e-05	0.000634	CcSEcCtD
Propafenone—Pruritus—Formoterol—chronic obstructive pulmonary disease	6.27e-05	0.000626	CcSEcCtD
Propafenone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	6.27e-05	0.000626	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000624	CcSEcCtD
Propafenone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000624	CcSEcCtD
Propafenone—Asthenia—Montelukast—chronic obstructive pulmonary disease	6.22e-05	0.000621	CcSEcCtD
Propafenone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000616	CcSEcCtD
Propafenone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	6.16e-05	0.000615	CcSEcCtD
Propafenone—Pruritus—Montelukast—chronic obstructive pulmonary disease	6.14e-05	0.000613	CcSEcCtD
Propafenone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	6.06e-05	0.000605	CcSEcCtD
Propafenone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	6.06e-05	0.000605	CcSEcCtD
Propafenone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	6.03e-05	0.000602	CcSEcCtD
Propafenone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.0006	CcSEcCtD
Propafenone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	6e-05	0.000599	CcSEcCtD
Propafenone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000596	CcSEcCtD
Propafenone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	5.93e-05	0.000593	CcSEcCtD
Propafenone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	5.92e-05	0.000591	CcSEcCtD
Propafenone—Erythema—Prednisolone—chronic obstructive pulmonary disease	5.88e-05	0.000587	CcSEcCtD
Propafenone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	5.86e-05	0.000585	CcSEcCtD
Propafenone—Dizziness—Formoterol—chronic obstructive pulmonary disease	5.86e-05	0.000585	CcSEcCtD
Propafenone—Dizziness—Montelukast—chronic obstructive pulmonary disease	5.74e-05	0.000573	CcSEcCtD
Propafenone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	5.72e-05	0.000571	CcSEcCtD
Propafenone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000564	CcSEcCtD
Propafenone—Vomiting—Formoterol—chronic obstructive pulmonary disease	5.63e-05	0.000562	CcSEcCtD
Propafenone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	5.63e-05	0.000562	CcSEcCtD
Propafenone—Rash—Formoterol—chronic obstructive pulmonary disease	5.58e-05	0.000558	CcSEcCtD
Propafenone—Rash—Arformoterol—chronic obstructive pulmonary disease	5.58e-05	0.000558	CcSEcCtD
Propafenone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	5.58e-05	0.000557	CcSEcCtD
Propafenone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	5.58e-05	0.000557	CcSEcCtD
Propafenone—Weight increased—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.000557	CcSEcCtD
Propafenone—Headache—Arformoterol—chronic obstructive pulmonary disease	5.55e-05	0.000554	CcSEcCtD
Propafenone—Headache—Formoterol—chronic obstructive pulmonary disease	5.55e-05	0.000554	CcSEcCtD
Propafenone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000554	CcSEcCtD
Propafenone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	5.54e-05	0.000553	CcSEcCtD
Propafenone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	5.53e-05	0.000552	CcSEcCtD
Propafenone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.000552	CcSEcCtD
Propafenone—Vomiting—Montelukast—chronic obstructive pulmonary disease	5.51e-05	0.000551	CcSEcCtD
Propafenone—Rash—Montelukast—chronic obstructive pulmonary disease	5.47e-05	0.000546	CcSEcCtD
Propafenone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	5.46e-05	0.000546	CcSEcCtD
Propafenone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	5.45e-05	0.000544	CcSEcCtD
Propafenone—Depression—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000544	CcSEcCtD
Propafenone—Headache—Montelukast—chronic obstructive pulmonary disease	5.43e-05	0.000543	CcSEcCtD
Propafenone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	5.36e-05	0.000535	CcSEcCtD
Propafenone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	5.32e-05	0.000531	CcSEcCtD
Propafenone—Malaise—Prednisolone—chronic obstructive pulmonary disease	5.3e-05	0.000529	CcSEcCtD
Propafenone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	5.28e-05	0.000527	CcSEcCtD
Propafenone—Rash—Salbutamol—chronic obstructive pulmonary disease	5.27e-05	0.000526	CcSEcCtD
Propafenone—Syncope—Prednisolone—chronic obstructive pulmonary disease	5.27e-05	0.000526	CcSEcCtD
Propafenone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	5.27e-05	0.000526	CcSEcCtD
Propafenone—Nausea—Arformoterol—chronic obstructive pulmonary disease	5.26e-05	0.000525	CcSEcCtD
Propafenone—Nausea—Formoterol—chronic obstructive pulmonary disease	5.26e-05	0.000525	CcSEcCtD
Propafenone—Headache—Salbutamol—chronic obstructive pulmonary disease	5.24e-05	0.000523	CcSEcCtD
Propafenone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	5.16e-05	0.000516	CcSEcCtD
Propafenone—Nausea—Montelukast—chronic obstructive pulmonary disease	5.15e-05	0.000514	CcSEcCtD
Propafenone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	5.09e-05	0.000508	CcSEcCtD
Propafenone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	5.07e-05	0.000507	CcSEcCtD
Propafenone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000499	CcSEcCtD
Propafenone—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.97e-05	0.000496	CcSEcCtD
Propafenone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4.94e-05	0.000494	CcSEcCtD
Propafenone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.000492	CcSEcCtD
Propafenone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.00049	CcSEcCtD
Propafenone—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000481	CcSEcCtD
Propafenone—Oedema—Prednisolone—chronic obstructive pulmonary disease	4.8e-05	0.000479	CcSEcCtD
Propafenone—Shock—Prednisolone—chronic obstructive pulmonary disease	4.72e-05	0.000471	CcSEcCtD
Propafenone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	4.68e-05	0.000467	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	4.66e-05	0.00199	CbGpPWpGaD
Propafenone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	4.64e-05	0.000463	CcSEcCtD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.6e-05	0.00196	CbGpPWpGaD
Propafenone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000458	CcSEcCtD
Propafenone—Flushing—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000455	CcSEcCtD
Propafenone—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.5e-05	0.00192	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.47e-05	0.00191	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.45e-05	0.0019	CbGpPWpGaD
Propafenone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000444	CcSEcCtD
Propafenone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	4.45e-05	0.0019	CbGpPWpGaD
Propafenone—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000442	CcSEcCtD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	4.42e-05	0.00189	CbGpPWpGaD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.00187	CbGpPWpGaD
Propafenone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000438	CcSEcCtD
Propafenone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	4.34e-05	0.000433	CcSEcCtD
Propafenone—Alopecia—Prednisone—chronic obstructive pulmonary disease	4.33e-05	0.000433	CcSEcCtD
Propafenone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	4.33e-05	0.00185	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.33e-05	0.00185	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	4.31e-05	0.00184	CbGpPWpGaD
Propafenone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	4.31e-05	0.00043	CcSEcCtD
Propafenone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000429	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.29e-05	0.00183	CbGpPWpGaD
Propafenone—Erythema—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000426	CcSEcCtD
Propafenone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000426	CcSEcCtD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.2e-05	0.00179	CbGpPWpGaD
Propafenone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.00179	CbGpPWpGaD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.00178	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.16e-05	0.00177	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	4.12e-05	0.00176	CbGpPWpGaD
Propafenone—Pain—Prednisolone—chronic obstructive pulmonary disease	4.1e-05	0.00041	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.09e-05	0.00175	CbGpPWpGaD
Propafenone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000402	CcSEcCtD
Propafenone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000396	CcSEcCtD
Propafenone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.95e-05	0.000395	CcSEcCtD
Propafenone—Anaemia—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000394	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.93e-05	0.00168	CbGpPWpGaD
Propafenone—Malaise—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000385	CcSEcCtD
Propafenone—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000383	CcSEcCtD
Propafenone—Syncope—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000382	CcSEcCtD
Propafenone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.81e-05	0.00038	CcSEcCtD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.78e-05	0.00161	CbGpPWpGaD
Propafenone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.75e-05	0.000375	CcSEcCtD
Propafenone—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.74e-05	0.0016	CbGpPWpGaD
Propafenone—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	3.71e-05	0.00158	CbGpPWpGaD
Propafenone—Convulsion—Prednisone—chronic obstructive pulmonary disease	3.7e-05	0.000369	CcSEcCtD
Propafenone—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.7e-05	0.00158	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.69e-05	0.00157	CbGpPWpGaD
Propafenone—Hypertension—Prednisone—chronic obstructive pulmonary disease	3.69e-05	0.000368	CcSEcCtD
Propafenone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.67e-05	0.00156	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.65e-05	0.00156	CbGpPWpGaD
Propafenone—Myalgia—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000363	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.63e-05	0.00155	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.62e-05	0.00155	CbGpPWpGaD
Propafenone—Anxiety—Prednisone—chronic obstructive pulmonary disease	3.62e-05	0.000362	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000361	CcSEcCtD
Propafenone—Discomfort—Prednisone—chronic obstructive pulmonary disease	3.59e-05	0.000359	CcSEcCtD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.56e-05	0.00152	CbGpPWpGaD
Propafenone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	3.53e-05	0.000353	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.52e-05	0.0015	CbGpPWpGaD
Propafenone—Oedema—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000348	CcSEcCtD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	3.47e-05	0.00148	CbGpPWpGaD
Propafenone—Infection—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000346	CcSEcCtD
Propafenone—Shock—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.000342	CcSEcCtD
Propafenone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000341	CcSEcCtD
Propafenone—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	3.41e-05	0.00145	CbGpPWpGaD
Propafenone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	3.4e-05	0.00034	CcSEcCtD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.00145	CbGpPWpGaD
Propafenone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000338	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.37e-05	0.00144	CbGpPWpGaD
Propafenone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	3.37e-05	0.000336	CcSEcCtD
Propafenone—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.35e-05	0.00143	CbGpPWpGaD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.34e-05	0.00143	CbGpPWpGaD
Propafenone—Anorexia—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.000332	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.18e-05	0.000317	CcSEcCtD
Propafenone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.17e-05	0.000317	CcSEcCtD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.17e-05	0.00135	CbGpPWpGaD
Propafenone—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000315	CcSEcCtD
Propafenone—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.13e-05	0.00134	CbGpPWpGaD
Propafenone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.13e-05	0.000312	CcSEcCtD
Propafenone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.12e-05	0.00133	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.11e-05	0.00133	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.1e-05	0.00132	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.08e-05	0.00131	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.08e-05	0.00131	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.00131	CbGpPWpGaD
Propafenone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000306	CcSEcCtD
Propafenone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.05e-05	0.0013	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.00129	CbGpPWpGaD
Propafenone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000303	CcSEcCtD
Propafenone—Rash—Prednisolone—chronic obstructive pulmonary disease	3.02e-05	0.000302	CcSEcCtD
Propafenone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.02e-05	0.000302	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.02e-05	0.00129	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.01e-05	0.00129	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.01e-05	0.00128	CbGpPWpGaD
Propafenone—Fatigue—Prednisone—chronic obstructive pulmonary disease	3e-05	0.0003	CcSEcCtD
Propafenone—Headache—Prednisolone—chronic obstructive pulmonary disease	3e-05	0.0003	CcSEcCtD
Propafenone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3e-05	0.00128	CbGpPWpGaD
Propafenone—Constipation—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000298	CcSEcCtD
Propafenone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.87e-05	0.000287	CcSEcCtD
Propafenone—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.87e-05	0.00122	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.87e-05	0.00122	CbGpPWpGaD
Propafenone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.85e-05	0.000285	CcSEcCtD
Propafenone—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.85e-05	0.000284	CcSEcCtD
Propafenone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.83e-05	0.00121	CbGpPWpGaD
Propafenone—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.77e-05	0.000276	CcSEcCtD
Propafenone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.75e-05	0.000275	CcSEcCtD
Propafenone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.75e-05	0.000275	CcSEcCtD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.75e-05	0.00117	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.00116	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.68e-05	0.00114	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.68e-05	0.00114	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.64e-05	0.00112	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.61e-05	0.00111	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.58e-05	0.0011	CbGpPWpGaD
Propafenone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.57e-05	0.000256	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.57e-05	0.0011	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.56e-05	0.00109	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.00109	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.54e-05	0.00109	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.54e-05	0.00108	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.53e-05	0.00108	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.51e-05	0.00107	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.51e-05	0.00107	CbGpPWpGaD
Propafenone—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.5e-05	0.00025	CcSEcCtD
Propafenone—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.47e-05	0.000246	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	2.44e-05	0.00104	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.43e-05	0.00104	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.42e-05	0.00103	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.00102	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.39e-05	0.00102	CbGpPWpGaD
Propafenone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.38e-05	0.000238	CcSEcCtD
Propafenone—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.35e-05	0.001	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.34e-05	0.000996	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.33e-05	0.000996	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000991	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.31e-05	0.000987	CbGpPWpGaD
Propafenone—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.3e-05	0.00023	CcSEcCtD
Propafenone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.3e-05	0.000982	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.000979	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.29e-05	0.000977	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.29e-05	0.000977	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.25e-05	0.000961	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000952	CbGpPWpGaD
Propafenone—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000221	CcSEcCtD
Propafenone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.21e-05	0.000944	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000939	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.2e-05	0.000939	CbGpPWpGaD
Propafenone—Rash—Prednisone—chronic obstructive pulmonary disease	2.2e-05	0.000219	CcSEcCtD
Propafenone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.2e-05	0.000219	CcSEcCtD
Propafenone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.19e-05	0.000933	CbGpPWpGaD
Propafenone—Headache—Prednisone—chronic obstructive pulmonary disease	2.18e-05	0.000218	CcSEcCtD
Propafenone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.18e-05	0.000931	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.18e-05	0.00093	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.18e-05	0.00093	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.17e-05	0.000926	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.14e-05	0.000914	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.1e-05	0.000896	CbGpPWpGaD
Propafenone—Nausea—Prednisone—chronic obstructive pulmonary disease	2.07e-05	0.000207	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.07e-05	0.000882	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.03e-05	0.000866	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.02e-05	0.000863	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000857	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.01e-05	0.000856	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.99e-05	0.000851	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000845	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.97e-05	0.000839	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.91e-05	0.000813	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.9e-05	0.00081	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.89e-05	0.000807	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000796	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.000777	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.8e-05	0.000766	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.78e-05	0.00076	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.77e-05	0.000756	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.68e-05	0.000715	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000705	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.63e-05	0.000695	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.61e-05	0.000686	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000666	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.000657	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.54e-05	0.000657	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.52e-05	0.000649	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000648	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000623	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.45e-05	0.000619	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.45e-05	0.000618	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.44e-05	0.000616	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000614	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000613	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.41e-05	0.000601	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.4e-05	0.000597	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000565	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.32e-05	0.000562	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.31e-05	0.000559	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000554	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.3e-05	0.000553	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.27e-05	0.000542	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.26e-05	0.000539	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.24e-05	0.000529	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000529	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.24e-05	0.000528	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.000524	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.19e-05	0.000508	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.18e-05	0.000503	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.18e-05	0.000502	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.17e-05	0.000501	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.17e-05	0.000499	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.16e-05	0.000494	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.15e-05	0.00049	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.14e-05	0.000487	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.000484	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000463	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.08e-05	0.000459	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.07e-05	0.000455	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000446	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.03e-05	0.000439	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.02e-05	0.000435	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.01e-05	0.00043	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	9.99e-06	0.000426	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	9.8e-06	0.000418	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.79e-06	0.000418	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	9.37e-06	0.0004	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.18e-06	0.000392	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.11e-06	0.000389	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.07e-06	0.000387	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	8.75e-06	0.000373	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.5e-06	0.000363	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.43e-06	0.00036	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.78e-06	0.000332	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.78e-06	0.000332	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.71e-06	0.000329	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.7e-06	0.000329	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	7.61e-06	0.000325	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.57e-06	0.000323	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.26e-06	0.00031	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.1e-06	0.000303	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.03e-06	0.0003	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.01e-06	0.000299	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.95e-06	0.000297	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.95e-06	0.000296	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.71e-06	0.000286	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.63e-06	0.000283	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.4e-06	0.000273	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.36e-06	0.000271	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.32e-06	0.00027	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.32e-06	0.00027	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.27e-06	0.000267	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.25e-06	0.000267	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	6.2e-06	0.000264	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.08e-06	0.00026	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.05e-06	0.000258	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.88e-06	0.000251	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.78e-06	0.000246	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.7e-06	0.000243	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.66e-06	0.000241	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.65e-06	0.000241	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.58e-06	0.000238	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.36e-06	0.000229	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.34e-06	0.000228	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.29e-06	0.000226	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.26e-06	0.000225	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.25e-06	0.000224	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.21e-06	0.000222	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.94e-06	0.000211	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.91e-06	0.000209	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.83e-06	0.000206	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.65e-06	0.000198	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.65e-06	0.000198	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.65e-06	0.000198	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.59e-06	0.000196	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.44e-06	0.000189	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.38e-06	0.000187	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.34e-06	0.000185	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.32e-06	0.000184	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.28e-06	0.000183	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.27e-06	0.000182	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.24e-06	0.000181	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.13e-06	0.000176	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.09e-06	0.000174	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.05e-06	0.000173	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.03e-06	0.000172	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.99e-06	0.00017	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.82e-06	0.000163	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-06	0.000161	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.76e-06	0.00016	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.73e-06	0.000159	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.71e-06	0.000158	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.66e-06	0.000156	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.57e-06	0.000152	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.44e-06	0.000147	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.41e-06	0.000146	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.4e-06	0.000145	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.23e-06	0.000138	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.16e-06	0.000135	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.05e-06	0.00013	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.02e-06	0.000129	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.87e-06	0.000122	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.83e-06	0.000121	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.8e-06	0.00012	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.75e-06	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.75e-06	0.000117	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.63e-06	0.000112	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.63e-06	0.000112	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.6e-06	0.000111	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-06	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.5e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-06	0.000105	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.31e-06	9.84e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.2e-06	9.38e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.11e-06	9.01e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.1e-06	8.97e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.7e-06	7.24e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.62e-06	6.92e-05	CbGpPWpGaD
